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Abstract 31 
Objective: Ultrafast and whole-body cooling can be induced by total liquid ventilation (TLV) 32 
with temperature-controlled perfluorocarbons.Our goal was to determine whether this can 33 
afford maximal cardio- and neuroprotections through cooling rapidity when coronary 34 
occlusion is complicated by cardiac arrest.  35 
Design: Prospective, randomized animal study.  36 
Setting: Academic research laboratory.  37 
Subjects: Male New-Zealand rabbits.  38 
Interventions: Chronically instrumented rabbits were submitted to coronary artery occlusion 39 
and ventricular fibrillation. After 8-min of cardiac arrest, animals were resuscitated and 40 
submitted to a normothermic follow-up (Control group) or to 3-h of mild hypothermia induced 41 
by TLV (TLV group) or by combination of cold saline infusion and cold blankets application 42 
(Saline group). Coronary reperfusion was permitted 40-min after the onset of occlusion. After 43 
awakening, rabbits were followed during 7 days. 44 
Measurements and main results: Ten animals were resuscitated in each group. In the 45 
Control group, all animals secondarily died from cardiac/respiratory failure (8/10) or 46 
neurological dysfunction (2/10). In the Saline group, the target temperature of 32°C was 47 
achieved within 30-45 min after cooling initiation. This slightly reduced infarct size vs Control 48 
(41±16% vs 54±8% of risk zone, respectively; p<0.05) but failed to significantly improve 49 
cardiac output, neurological recovery and survival rate (3 survivors, 6 death from 50 
cardiac/respiratory failure and 1 from neurological dysfunction).  Conversely, the 32°C 51 
temperature was achieved within 5-10 min in the TLV group. This led to a dramatic reduction 52 
in infarct size (13±4%; p<0.05 vs other groups) and improvements in cardiac output, 53 
neurological recovery and survival (8 survivors, 2 deaths from cardiac/respiratory failure). 54 
Conclusions: Achieving hypothermia rapidly is critical to improve the cardiovascular 55 
outcome after cardiac arrest with underlying myocardial infarction.  56 
 57 
58 
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Introduction 59 
 Out-of-hospital cardiac arrest is a leading cause of death in the world. After 60 
cardiopulmonary resuscitation, comatose survivors require integrated post-resuscitation care 61 
(1). Among the recommended treatments, hypothermia provides neuroprotection (2) while 62 
percutaneous coronary interventions is intended for revascularization during coronary artery 63 
occlusion (CAO) (3). Since hypothermia also decreases myocardial susceptibility to ischemia 64 
(4-6), it could potentiate the cardioprotective effect of reperfusion therapies and further 65 
improve hemodynamics when cardiac arrest is associated with coronary obstruction. This 66 
cardiac benefit could however be compromised if hypothermia is only achieved into the 67 
coronary reperfusion phase (4-6), supporting the importance of cooling the heart quickly. 68 
This importance has also been evidenced for the neurological effect of hypothermia in animal 69 
models of global (7-10) and brain (11) ischemia. Here, we hypothesize that rapidity of cooling 70 
is also critical to achieve maximal protection and to prevent cardiovascular mortality when 71 
cardiac arrest is combined with CAO. 72 
 In order to investigate the importance of the cooling rate, we previously studied ultra-73 
fast cooling through total liquid ventilation (TLV). It consists in the tidal ventilation of lungs 74 
with temperature-controlled perfluorocarbons that can cool the body while maintaining gas 75 
exchanges (12). After global ischemia, TLV provided a greater neurological benefit and 76 
survival improvement than a conventional cooling in a rabbit model (12). The superiority of 77 
TLV was also shown regarding infarct size reduction in rabbits submitted to CAO (5, 6, 13). 78 
Importantly, these previous studies were conducted in pure models of cardiac arrest or CAO 79 
but they did not reproduce the complexe interactions occuring in vivo during their 80 
combination, as often observed in patients (1, 3).  81 
 In the present study, we aimed to determine whether cooling rapidity, assessed by 82 
comparison of TLV with a conventional “load-dependent” hypothermia (cold saline infusion 83 
plus external cooling), could be actually critical to achieve maximal cardiac, neurological and 84 
survival benefits after combined cardiac arrest and CAO in chronically instrumented rabbits. 85 
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Materials and Methods 86 
 The experiments were conducted in accordance with French official regulations, after 87 
approval by the local ethical review board. They conformed to the “Position of the American 88 
Heart Association on research animal use”. 89 
Animal preparation 90 
 Male New-Zealand rabbits were anesthetized using zolazepam, tiletamine and 91 
pentobarbital (all 20-30 mg/kg i.v.). They were chronically instrumented with a peri-coronary 92 
pneumatic occluder, an aortic cardiac output probe (PS-Series Probes, Transonic, NY, USA) 93 
and an electrode upon the chest.  94 
Coronary occlusion, cardiac arrest and cardiopulmonary resuscitation 95 
 Two weeks after surgery, animals were reanesthetized, intubated and mechanically 96 
ventilated (Fi02=100%; Vt=10 ml/kg; 26 breaths/min). The peri-coronary occluder was 97 
inflated to induce CAO. Two minutes later, ventricular fibrillation was induced by passing an 98 
alternating current (10 V, 4 mA) between the chest electrode and another electrode within 99 
the esophagus. After 8 min of untreated fibrillation, cardiopulmonary resuscitation was 100 
started using manual lateral chest compressions (~200 compressions/min), electric attempts 101 
of defibrillation (5-10 J/kg) and intravenous administration of epinephrine (15 µg/kg i.v.). 102 
Mechanical ventilation was stopped throughout the cardiac arrest period and restarted at the 103 
onset of cardiopulmonary resuscitation. Resumption of spontaneous circulation (ROSC) was 104 
considered as an organized cardiac rhythm associated with a mean arterial pressure above 105 
40 mmHg during at least 1 min. Coronary reperfusion was permitted through occluder 106 
deflation after 40 min of CAO. After ROSC, administration of epinephrine was permitted 107 
during 7 h to maintain mean arterial pressure at ~80 mmHg. Mechanical ventilation was 108 
continued until awakening of the animals.  109 
110 
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Experimental protocol 111 
 After ROSC, rabbits randomly underwent life support under normothermic conditions 112 
(Control group) or with therapeutic hypothermia (TLV and Saline groups). In the TLV group, 113 
hypothermia was induced by 20 min of liquid ventilation after filling the lungs with 10 ml/kg of 114 
perfluorodecalin, as previously described (5, 6, 12, 13). The liquid ventilator was set initially 115 
to a respiratory rate of 6 breaths/min and a tidal volume of ~7-10 ml/kg. If necessary, 116 
ventilatory parameters were adjusted to maintain saturation of peripheral oxygen (SpO2) over 117 
90%. The temperature of perfluorocarbon was initially set at 20°C and progressively 118 
increased to 32°C to maintain oesophageal temperatures at ~32°C. After 20 min of TLV, 119 
animals resumed to conventional gas ventilation. In the Saline group, hypothermia was 120 
induced by cold blankets over the skin and infusion of cold (4°C) saline (NaCl 0.9%, 30 ml/kg 121 
i.v. over 30 min). In both Saline and TLV groups, hypothermia was maintained externally at 122 
32°C during 3 h after the onset of the cooling protocol. Subsequently, animals were actively 123 
rewarmed using thermal pads and infrared lights until weaning from conventional ventilation 124 
and awakening.  125 
Investigated parameters 126 
 Hemodynamic parameters were continuously recorded using external 127 
electrocardiogram, blood pressure in the ear artery and cardiac output flowmeter (Flowmeter-128 
T206, Transonic, NY, USA).  129 
 Throughout the 7 days following cardiac arrest, the animals underwent a regular 130 
survival and clinical follow-up. Neurological dysfunction was assessed using a previously 131 
described score system (0-10% = normal; 100% = brain death) (12, 14). In accordance with 132 
the ethical committee, the animals showing a neurological dysfunction score above 60% 133 
during 48 hours were euthanized and considered as dead from neurological dysfunction. At 134 
the end of the 7 days of follow-up, surviving rabbits were reanesthetized and a pressure 135 
catheter (SciSense, London, Ontario, Canada) was introduced into the left ventricle for 136 
measurement of end-diastolic pressure and left ventricular rate of pressure development. 137 
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These parameters were also measured in a group of Sham rabbits neither submitted to 138 
cardiac arrest nor hypothermia. 139 
Post-mortem analysis 140 
 Seven days after cardiac arrest, surviving animals were euthanized for organ 141 
sampling. Pathological analyses were also conducted in the animals that died prematurily. In 142 
the heart, risk zone and infarct sizes were determined using triphenyltetrazolium chloride 143 
staining (5, 13). In all organs, the lesion severity was assessed by histology and quantified 144 
using a 0-3 score system (12). For the brain, a neuropathologist semi-quantitatively and 145 
blindly assessed the amount of ischemic neurons in the cortex, hippocampus and 146 
cerebellum, as previously described (12). The brain score was the mean value obtained for 147 
these three areas. For lungs, we assessed two separate scores for cardiogenic lesions 148 
(serous edema and/or congestion) and infectious complication of bronchopneumonia, 149 
respectively (12).  In the myocardium, these analyses were performed in a remote area, out 150 
of the risk zone.  151 
Statistical analyses 152 
 Data were expressed as mean±SD. The normality of data distribution was tested 153 
using the Kolmogorov-Smirnov analysis. For normally distributed parameters, comparisons 154 
were made between groups using a one-way ANOVA at selected time-points as the number 155 
of animals varied among time. Post-hoc analyses were performed using the Fisher Least 156 
Significant Difference Method. For non-normally distributed parameters, neurological 157 
dysfunction and histological scores, comparisons were made using a non-parametric 158 
Kruskall-Wallis test followed by a Mann-Whitney analysis. Survival curves were obtained 159 
using a Kaplan-Meier analysis and compared between group using a log-rank test. 160 
Significant differences were determined at P≤0.05. 161 
162 
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Results 163 
 Out of the 40 rabbits submitted to cardiac arrest, 30 animals were successfully 164 
resuscitated and included in the final experimental groups (n=10 / group). The time to ROSC 165 
was 2.9±0.8, 2.8±1.4 and 3.1±1.4 min in Control, TLV and Saline groups, respectively. 166 
Temperatures decreased very rapidly after the onset of cooling in TLV as compared to Saline 167 
group (Figure 2).  168 
TLV prevents early hemodynamic dysfunction 169 
 As illustrated in Figure 3, TLV reduced left ventricular dysfunction after resuscitation. 170 
After 30 min of CAO, cardiac output and stroke volumes were indeed increased in TLV vs 171 
Control and Saline groups. Heart rate was conversely decreased throughout hypothermia in 172 
both TLV and Saline groups (Table I). One day after cardiac arrest, cardiac output was again 173 
increased in survivors of the TLV group as compared to Control and Saline groups. 174 
Hypothermia also decreased the amount of epinephrine required to maintain mean arterial 175 
pressure at ~80 mmHg after cardiac arrest (336±209, 305±153 vs 751±488 µg/kg in TLV and 176 
Saline vs Control groups, respectively; p<0.05). Troponin I blood release was also 177 
dramatically attenuated in TLV vs Control and Saline groups (Table II). 178 
TLV improves cardiovascular outcome and provides cardioprotection 179 
 As shown in Figure 4 (Panels A-B), the hemodynamic improvements observed in the 180 
TLV group was associated with a reduced mortality, in particular from cardiovascular and/or 181 
respiratory failures. Seven days after cardiac arrest, the survival rate achieved 80% in TLV 182 
group vs 0% and 30% in Control and Saline groups, respectively. As shown in Table III, left 183 
ventricular performance was not altered in survivors of the TLV group as compared to Sham 184 
animals, suggesting a complete recovery. Conversely, a pattern of heart failure was 185 
observed in the 2 surviving rabbits of the Saline group.  186 
 Despite similar risk zone sizes in all groups (35±7, 34±6 and 40±6 % of the left 187 
ventricle, respectively), the functional benefit of TLV was combined to a potent reduction in 188 
infarct size vs Saline and Control groups (Figure 5A). Myocardial necrosis out of the risk 189 
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zone was also significantly limited by TLV as compared to Control and Saline groups (Figure 190 
5, Panels B-D).  191 
TLV limits lung cardiogenic lesions 192 
 As shown in Table IV, a metabolic acidosis was observed in all groups after cardiac 193 
arrest. One hour after coronary reperfusion, blood PO2 and pH were improved in TLV vs 194 
Control and Saline groups. At necropsy, lung examination showed reduced lung cardiogenic 195 
lesions in TLV vs Control and Saline (Figure 6, Panels A-C). Foam macrophages were 196 
identified in the TLV group in 8/10 animals (Figure 6, Panel D), probably as a consequence 197 
of some perfluorocarbons persistence. Kidney and liver dysfunctions and lesions were 198 
moderate in all groups (Table II and Figure 6, Panels E-H).    199 
TLV limits neurological dysfunction 200 
 As illustrated in Figure 7 (Panel A), the neurological deficit score was significantly 201 
attenuated in the TLV group as compared to Control and Saline groups. This neuroprotective 202 
effect was also supported by limited brain ischemic lesions in TLV vs Control and Saline 203 
groups (Figure 7, Panels B-C). Large cerebral infarctions were observed in two rabbits from 204 
the Control and Saline groups, as well as one small and deep infarction in the TLV group. 205 
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Discussion 206 
 In the present study, we demonstrate that hypothermic TLV not only attenuates 207 
neurological injury and myocardial infarct size but also prevents acute cardiovascular 208 
dysfunction and mortality after combined CAO and cardiac arrest. The favourable effect of 209 
TLV was related to cooling rapidity as a slower cooling was not similarly efficient, despite 210 
similar target temperature (32°C).  211 
 In this study, we observed a severe post-cardiac arrest syndrom (1) with an intense 212 
cardiovascular dysfunction as acute CAO and cardiac arrest were associated. In Control 213 
conditions, mortality within the first 24 h reached 60% while it was only 30% in a previous 214 
report in a similar rabbit model with 10 min of shockable cardiac arrest without CAO (12). 215 
This model is especially relevant for evaluation of acute heart failure and myocardial stunning 216 
(15) after cardiac arrest. During the early phase of global stunning (i.e. prior to coronary 217 
reperfusion), a favourable effect of ultra-fast cooling was evidenced with TLV. This was 218 
probably a direct effect of hypothermia on ventricular contractility (16, 17) as previously 219 
observed during regional stunning in rabbits submitted to focal myocardial ischemia (5). In 220 
the present study, TLV further allowed an ultimate complete recovery of left ventricular 221 
function within the first 24 h, as probably related to its potent anti-infarct effect. These 222 
functional benefits were largely related to the rapidity of cooling since conventional and 223 
slower hypothermia did not provide similar effects on cardiac output and cardiovascular 224 
mortality. These results are in line with those of Yannopoulos et al. comparing cold saline 225 
infusion to endovascular cooling in a swine model of ischemic cardiac arrest (18). Infarct size 226 
reduction was again directly related to the time to reach the target temperature. In 227 
comparison, our present study further demonstrates that the rapidity of cooling is not only 228 
critical for infarct size reduction but more importantly for prevention of cardiovascular 229 
mortality. The hemodynamic improvement afforded by TLV was however poorly predicted by 230 
blood lactate levels.  231 
 Beyond its beneficial effect on cardiovascular outcomes, this study also evidenced 232 
the neuroprotective effect of TLV through enhanced neurological recovery and decreased 233 
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brain lesions. Conversely, conventional cooling was not as protective, as previously shown in 234 
a pure model of ventricular fibrillation (12). A benefit should however be evidenced with a 235 
larger number of animals as even “slow” hypothermia is known to afford a neurological 236 
benefit after cardiac arrest, although attenuated as compared to early hypothermia (7-10). 237 
This clearly contrasts with the cardioprotective effect of hypothermia that is virtually entirely 238 
lost when cooling is delayed (4-6). As an example, Knafelj et al. did not show any 239 
cardioprotective benefit of slow and externaly-induced hypothermia in survivors of ventricular 240 
fibrillation with ST-elevation acute myocardial infarction (STEMI), whereas cerebral 241 
performance category score was significantly improved (19). Clinical trials testing 242 
hypothermia in STEMI patients with no cardiac arrest also showed disapointing results when 243 
hypothermia was delayed (20) as compared to more precocious and aggressive cooling (21).  244 
 Taken together, all these findings clearly emphasized the major impact of the rapidity 245 
of cooling on outcome after combined CAO and cardiac arrest. As also observed in pigs (22, 246 
23) and despite its invasive nature, hypothermic TLV seems to provide additional benefits to 247 
postresuscitation care. In the latter studies, some lung toxicity was however observed with 248 
the perfluorocarbon Fluorinert™ FC-77. The current development of liquid ventilators 249 
appropriate for human uses will allow confirmation of the present results for a further clinical 250 
translation (24). In the present study, we used perfluorodecalin for TLV as this coumpound 251 
was recently approved for intrapulmonary administration and bronchoalveolar lavage 252 
(Perflubronc PFD ®, Origen, Austin, Texas, USA). Perfluorodecalin is also radiolucent while 253 
the well-known perfluorooctylbromide (Perflubronc PFB ®) is opaque on X ray with potential 254 
disavantages in case of a coronary angioplasty is required in future translations. 255 
Perfluorodecalin is also a viscous liquid with a low vapour pressure as compared to other 256 
perfluorocarbons. It will be necessary to test other perfluorocarbons with a higher vapour 257 
pressure and evaporating rate (e.g., perfluorooctane). In the future, it will also be important to 258 
confirm the present results in large animals as small ones poorly mimic human inflammation 259 
states (25), that are known to be critical after cardiac arrest.  260 
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 The present study has several limitations. First, a limited number of animals were 261 
euthanized for ethical reasons before the end of the follow-up (i.e., 3 Control animals). This 262 
was conducted after 48 h of follow-up when certain and rapid death was expected. Our 263 
survival analyses therefore took into account spontaneous deaths but also decision to 264 
sacrifice highly disabled animals in rare cases. Second, we did not measure coronary 265 
perfusion pressure during the cardiac massage. It would be relevant to investigate the 266 
massage efficiency.   267 
 268 
269 
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Conclusion 270 
 In conclusion, ultra-fast cooling dramatically improved the cardiovascular outcome 271 
after cardiac arrest with underlying coronary artery occlusion. Further reports should confirm 272 
these results in larger species. 273 
 274 
275 
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Figures legends 350 
 351 
Figure 1: Schematic representation of the experimental protocol.  352 
CAO, coronary artery occlusion; CA, cardiac arrest; ROSC, Resumption of spontaneous 353 
circulation; TLV, Total Liquid Ventilation; Saline, hypothermia induced by intravenous 354 
administration of cold saline combined to external cooling 355 
 356 
Figure 2: Esophageal, tympanic and rectal temperatures.  357 
Statistical analyses was performed at baseline (B; n=10 in each group), at t=30 min of CAO 358 
(n=10 in each group), at t=180 min of reperfusion (n=9, 10 and 9 in Control, TLV and Saline, 359 
respectively) and t=480 min of reperfusion (n=7, 9 and 8 in Control, TLV and Saline, 360 
respectively). See legend of Figure 1;  *, p<0.05 vs corresponding Control; †, p<0.05 vs 361 
corresponding Saline. 362 
 363 
Figure 3: Cardiac output, peripheral vascular resistances and left ventricular stroke volume.  364 
See legend of Figure 2.  365 
. 366 
Figure 4:  367 
Panel A: Kaplan-Meyer survival curves throughout the 7 days following coronary artery 368 
occlusion and cardiac arrest in the different experimental groups.  369 
Panel B: Number of animals deceased before 7 days of survival follow-up in each group, 370 
according the suspected cause of death (cardiogenic vs neurological death).  371 
See legend of Figure 2.  372 
 373 
374 
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Figure 5: 375 
Panel A: Infarct sizes (as percentage of the risk zone). Open and closed circles represent 376 
individual and mean infarct sizes, respectively. 377 
Panel B: Histopathological scores of the myocardium in a territory remote to the risk zone. 378 
Lesions consisted of foci of necrosis (0=normal; 3 = frequent foci). Open circles represents 379 
individual scores. 380 
Panel C: Histopathological appearance of the myocardium remote to the risk zone in a rabbit 381 
from the Control group.  382 
Panel D: Normal histological appearance of the myocardium remote to the risk zone in a 383 
rabbit from the TLV group. The blue dye stains microvessels out of the risk zone. 384 
See legend of Figure 2.  385 
 386 
Figure 6: 387 
Panels A and B: Histopathological scores of cardiogenic lesions and infectious 388 
complications in the lungs, respectively. Open circles represents individual scores. 389 
Panel C: Histopathological appearance of the lung of a rabbit in the Control group. Lesions 390 
consisted of extensive serous edema within the alveolae (arrows). 391 
Panel D: Histopathological appearance of the lung of a rabbit in the TLV group. Foam 392 
macrophages can be seen within the alveolae (arrows). 393 
Panels E and F: Histopathological scores of alteration of the kidney and liver, respectively. 394 
Open circles represents individual scores. 395 
Panel G: Histopathological appearance of the kidney in the Control group. Lesions consisted 396 
of mildly dilated proximal tubules.  397 
Panel H: Histopathological appearance of the liver of a rabbit in the Control group. Lesions 398 
consisted of systematized centrilobular congestion of the sinusoids.  399 
See legend of Figure 2.  400 
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Figure 7: 402 
Panel A: Neurological dysfunction scores at days 1 and 7 after coronary artery occlusion and 403 
cardiac arrest in the different experimental groups. Open circles represent individual scores 404 
and the thick line represents the median value of the corresponding group.  405 
Panel B: Histopathological scores of alteration of the brain. Open circles represents 406 
individual scores. 407 
Panel C: Histopathological appearance of the brain in one rabbit of the Control group. 408 
Lesions consisted in a cerebral infarction (arrow). 409 
Panel D: Histopathological appearance of the hippocampus in one rabbit of the Saline group.  410 
Panel E: Normal histological appearance of the hippocampus in one rabbit of the TLV group.  411 
See legend of Figure 2.  412 
 413 
1 
Table I: Heart rate and mean arterial pressure  
CAO Coronary reperfusion   
  Baseline 
1 min 30 min 180 min 480 min Day 1 Day 7 
        
Number of animals (n) 
 Control 10 10 10 9 8 4 0 
 TLV 10 10 10 10 9 9 8 
 Saline 10 10 10 9 9 6 3 
        
Heart rate (beats/min) 
Control 253±25 241±24 205±21 224±21 256±25 263±67 - 
TLV 257±25 234±30 145±19*† 161±21* 223±36 264±45 242±34 
Saline 255±34 231±30 197±34 148±14* 242±30 255±50 241±47 
        
Mean arterial pressure (mmHg) 
Control 78±11 60±16 89±12 79±9 78±8 70±15 - 
TLV 80±13 60±12 82±10 83±4 74±8 72±6 68±14 
Saline 77±9 55±11 81±5 79±5 77±9 77±12 74±14 
        
 
TLV, total liquid ventilation; Saline, hypothermia induced by intravenous administration of 
cold saline combined to external cooling; *, p<0.05 vs corresponding Control; †, p<0.05 vs 
corresponding Saline. 
 
2 
Table II: Troponin I, creatinine and alanine-aminotransferase (ALAT) blood levels 
Coronary reperfusion   
  Baseline 
60 min 360 min Day 1 
     
Number of animals (n) 
  Control  9 9 8 4 
  TLV  10 10 9 9 
  Saline 10 9 8 7 
     
Troponine I blood levels (ng/ml) 
  Control  < 0.2 151±62 147±58 111±50 
  TLV  < 0.2 8±11 *† 75±83 28±40 *† 
  Saline < 0.2 61±27 * 152±62 91±46 
     
Creatinine plasma levels (mg/l) 
  Control  5.9±1.3 9.3±2.2 8.5±2.9 9.4±5.2 
  TLV  6.8±1.6 7.8±2.8 7.3±1.7 8.5±2.8 
  Saline 7.4±2.7 6.4±3.5 5.2±2.9 6.1±3.2 
     
Alanine-aminotransferase plasma levels (UI/l) 
  Control  26±13 74±36 79±48 79±28 
  TLV  33±20 59±39 87±64 83±78 
  Saline 28±9 61±33 83±58 61±29 
     
 
See legend of Table I. 
3 
Table III: Hemodynamic parameters one week after cardiac arrest in surviving animals. 
In order to determine “usual” values, parameters were also assessed in Sham rabbits 
not submitted to cardiac arrest.  
 
 
Control TLV Saline Sham 
 
    
Number of animals (n) 0 8 2 8 
Left ventricular maximal rate of 
pressure development ( dP/dt max) - 4908±1130 1848±815 5535±2318 
Left ventricular minimal rate of 
pressure development ( dP/dt min) - 4270±1166 -1317±499 5339±1376 
Left ventricular maximal systolic 
pressure (mmHg) - 102±20 60±4 97±17 
End-diastolic left ventricular 
pressure (mmHg) - 6±2 14±6 4±1 
     
 
See legend of Table I. Statistical comparisons were only performed  between TLV and 
Sham groups (no difference); One rabbit died in the Saline group during anaesthesia 
before catheterization. 
 
 
4 
Table IV: Blood gases and lactate blood levels.  
Coronary reperfusion   
Baseline 
60 min 180 min Day 1 Day 7 
      
Number of animals (n) 
  Control 10 10 9 4 0 
  TLV 10 10 10 9 8 
  Saline 10 10 9 6 3 
      
Lactates blood levels (mmol/l) 
  Control 3.0±0.9 13.5±3.1 11.0±3.2 3.3±2.9 - 
  TLV 3.4±0.8 13.7±3.3 12.8±3.5 2.3±1.1 3.7±1.2 
  Saline 3.5±1.6 16.1±2.1 15.7±2.9 * 4.5±4.2 4.7±3.2 
      
Blood pH 
  Control 7.41±0.07 7.03±0.23 7.22±0.1 7.31±0.07 - 
  TLV 7.45±0.11 7.33±0.09 *† 7.29±0.15 7.32±0.15 7.38±0.06 
  Saline 7.38±0.06 7.15±0.09 7.15±0.09 7.21±0.11 7.36±0.09 
      
Blood pCO2 (torr) 
  Control 40±8 41±7 38±4 57±2 - 
  TLV 42±10 28±5 * 26±4 * 53±10 43±5 
  Saline 42±13 27±5 * 25±4 * 57±10 52±10 
      
Blood pO2 (torr) 
  Control 428±129 205±95 373±136 57±9 - 
  TLV 500±170 456±126 *† 354±204 56±18 78±19 
  Saline 526±76 283±121 305±114 46±10 67±26 
      
 
See legend of Table I. 
  







